Expanded Program on Immunization
Showing 1 - 25 of >10,000
Contraceptive Usage Trial in Hawassa (counseling)
Active, not recruiting
- Contraceptive Usage
- counseling
-
Hawassa, Sidama, EthiopiaSidama regional health bureau
Mar 1, 2021
Child Mortality Trial in Freetown (Azithromycin, Placebo)
Recruiting
- Child Mortality
- Azithromycin
- Placebo
-
Freetown, Sierra LeoneCollege of Medicine and Allied Health Sciences
Sep 7, 2021
Hepatitis B Trial in Cameroon (Integration of vaccination services into delivery services)
Completed
- Hepatitis B
- Integration of vaccination services into delivery services
-
Dibi, Adamawa, Cameroon
- +12 more
Jul 22, 2022
EPI,Missed Opportunity for Postpartum Family Planning
Recruiting
- Contraception
- counseling for family planning
-
Hawassa, Sidama, EthiopiaSidama regional health bureau
Feb 23, 2021
COVID-19 Trial in Langhorne (BBV152)
Available
- COVID-19
- BBV152
-
Langhorne, PennsylvaniaWoods
Sep 14, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
No longer available
- Thrombotic Thrombocytopenic Purpura (TTP)
- (no location specified)
Mar 3, 2023
Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)
Available
- Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
- Relapsed/Refractory Acute Myeloid Leukemia
- Magrolimab
- (no location specified)
Jan 18, 2023
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023
Ovarian Cancer in Expanded Access Program in Latin America
Not yet recruiting
- Ovarian Cancer
- Observational study
- (no location specified)
May 4, 2023
Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))
Available
- Hypoparathyroidism
- Palopegteriparatide (TransCon PTH)
- (no location specified)
Jan 10, 2023
Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome Trial (Tiratricol)
Available
- Monocarboxylate Transporter 8 Deficiency
- Allan-Herndon-Dudley Syndrome
- (no location specified)
Jun 9, 2023
Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)
Available
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Galinpepimut-S
- (no location specified)
Oct 20, 2022
HIV-1 Trial in Bobo-Dioulasso, Ouagadougou, Lusaka (Lamivudine Oral Solution)
Completed
- HIV-1
- Lamivudine Oral Solution
-
Bobo-Dioulasso, Burkina Faso
- +5 more
Dec 6, 2022
Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)
Available
- Large B-cell Lymphoma
- +4 more
- Epcoritamab
- (no location specified)
Feb 16, 2023
HIV-1 Trial in Bobo-Dioulasso (Lamivudine Oral Solution)
Active, not recruiting
- HIV-1
- Lamivudine Oral Solution
-
Bobo-Dioulasso, Burkina FasoPaulin Fao
Mar 29, 2022
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)
Available
- Cutaneous Melanoma, Stage III
- +3 more
- IFx-Hu2.0
- (no location specified)
Aug 5, 2022
Multiple Myeloma Trial (Cilta-cel OOS Therapy)
Available
- Multiple Myeloma
- Cilta-cel OOS Therapy
- (no location specified)
Aug 15, 2022
Acute Myeloid Leukemia, AML, AML, Adult Recurrent Trial (flotetuzumab)
No longer available
- Acute Myeloid Leukemia
- +2 more
- flotetuzumab
- (no location specified)
May 24, 2022
NSCLC Trial in Salvador, Belo Horizonte, São Paulo
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Salvador, Bahia, Brazil
- +3 more
Nov 28, 2022
COVID-19 Trial (Convalescent Plasma)
No longer available
- COVID-19
- Convalescent Plasma
- (no location specified)
Mar 14, 2022
Survivorship Wellness Group Program in Context of COVID-19 and
Recruiting
- COVID-19 Infection
- +2 more
- Survey Administration
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022